European Journal of Cancer
Volume 45, Issue 2 , Pages 248-260, January 2009

Individual patient data analysis to assess modifications to the RECIST criteria

  • Jan Bogaerts

      Affiliations

    • European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Avenue Mounierlaan, 83/11, Brussel 1200 Bruxelles, Belgium
    • Corresponding Author InformationCorresponding author: Tel.: +32 2 774 10 63; fax: +32 2 771 38 10.
    • ,
  • Robert Ford

      Affiliations

    • RadPharm, Princeton, USA
    • ,
  • Dan Sargent

      Affiliations

    • Mayo Clinic, Rochester, USA
    • ,
  • Lawrence H. Schwartz

      Affiliations

    • MSKCC, New York, USA
    • ,
  • Larry Rubinstein

      Affiliations

    • National Cancer Institute, Bethesda, USA
    • ,
  • Denis Lacombe

      Affiliations

    • European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Avenue Mounierlaan, 83/11, Brussel 1200 Bruxelles, Belgium
    • ,
  • Elizabeth Eisenhauer

      Affiliations

    • National Cancer Institute of Canada – Clinical Trials Group, Kingston, ON, Canada
    • ,
  • Jaap Verweij

      Affiliations

    • Erasmus University Medical Center, Rotterdam, The Netherlands
    • ,
  • Patrick Therasse

      Affiliations

    • GlaxoSmithKline Biologicals, Rixensart, Belgium
    • ,
  • for the RECIST Working Party

Received 17 October 2008; accepted 29 October 2008. published online 17 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(08)00874-5

doi:10.1016/j.ejca.2008.10.027

European Journal of Cancer
Volume 45, Issue 2 , Pages 248-260, January 2009

Article Tools